[go: up one dir, main page]

MX2019005682A - Metodos y dispositivos para la deteccion del virus de la hepatitis c. - Google Patents

Metodos y dispositivos para la deteccion del virus de la hepatitis c.

Info

Publication number
MX2019005682A
MX2019005682A MX2019005682A MX2019005682A MX2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A
Authority
MX
Mexico
Prior art keywords
methods
detection
devices
hcv
hepatitis virus
Prior art date
Application number
MX2019005682A
Other languages
English (en)
Inventor
J Clarke Nigel
Rogers Amy
A Leake John
e baumann Russell
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2019005682A publication Critical patent/MX2019005682A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C07K16/118—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación proporciona métodos rápidos y no invasivos para determinar si un paciente se beneficiará del tratamiento con agentes terapéuticos que inhiben al virus de la hepatitis C (VHC). Estos métodos se basan en detectar ARN de VHC y/o anticuerpos anti-VHC en muestras de fluidos biológicos secos de pequeño volumen, las cuales son recolectadas utilizando un dispositivo volumétrico absortivo de micromuestreo. Los kits para usarse en la práctica de los métodos también son proporcionados.
MX2019005682A 2016-11-15 2017-11-13 Metodos y dispositivos para la deteccion del virus de la hepatitis c. MX2019005682A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662422321P 2016-11-15 2016-11-15
US201662425263P 2016-11-22 2016-11-22
PCT/US2017/061303 WO2018093721A2 (en) 2016-11-15 2017-11-13 Methods and devices for detecting hepatitis c virus

Publications (1)

Publication Number Publication Date
MX2019005682A true MX2019005682A (es) 2019-10-30

Family

ID=62107725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005682A MX2019005682A (es) 2016-11-15 2017-11-13 Metodos y dispositivos para la deteccion del virus de la hepatitis c.

Country Status (8)

Country Link
US (2) US20180136211A1 (es)
EP (1) EP3541960A4 (es)
JP (2) JP2020511956A (es)
CN (1) CN110168111A (es)
BR (1) BR112019009798A2 (es)
CA (1) CA3044031A1 (es)
MX (1) MX2019005682A (es)
WO (1) WO2018093721A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11486005B2 (en) 2016-11-15 2022-11-01 Quest Diagnostics Investments Llc Methods for detecting cystic fibrosis mutations using mitra tip extraction
WO2021216780A1 (en) * 2020-04-21 2021-10-28 Biomerica, Inc. Collection devices for biological samples and methods of use thereof
EP3922140A3 (en) 2020-04-23 2022-02-16 Fasteners for Retail, Inc. Retail merchandise shelving system
CN113679701B (zh) * 2020-05-18 2024-04-30 中国科学院上海药物研究所 邻苯三酚及其衍生物作为共价配体反应弹头的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696329B2 (en) * 2006-06-23 2010-04-13 Florida State University Research Foundation, Inc. Immunoglobulin peptides against heated bovine blood
US20130116597A1 (en) * 2011-11-04 2013-05-09 Phenomenex, Inc. Method and apparatus for acquiring blood for testing

Also Published As

Publication number Publication date
EP3541960A4 (en) 2020-06-10
CN110168111A (zh) 2019-08-23
BR112019009798A2 (pt) 2019-08-06
WO2018093721A2 (en) 2018-05-24
US20180136211A1 (en) 2018-05-17
US20190276904A1 (en) 2019-09-12
EP3541960A2 (en) 2019-09-25
JP2020511956A (ja) 2020-04-23
WO2018093721A3 (en) 2018-06-21
CA3044031A1 (en) 2018-05-24
JP2022191225A (ja) 2022-12-27

Similar Documents

Publication Publication Date Title
CO2018009434A2 (es) Anticuerpos monoclonales de proteína ns1 anti-virus del dengue
MX2016005959A (es) Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción.
EP3584575A4 (en) INTEGRATED DEVICE FOR FECAL SAMPLING AND OCCULT BLOOD DETECTION
MX2017014736A (es) Metodos terapeuticos y diagnosticos para cancer.
MX2019005682A (es) Metodos y dispositivos para la deteccion del virus de la hepatitis c.
EA201790443A1 (ru) Универсальный анализ коагуляции на основе микрожидкостного чипа
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
MX2021006893A (es) Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo.
JP1754772S (ja) サンプル採取器具
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
AR110645A1 (es) Anticuerpos anti-hla-g y uso de los mismos
JOP20200216A1 (ar) تجارب للكشف عن التنكس العصبي
EP3798616A4 (en) Chemical luminescence analysis and measurement method, system using same, and kit
MX2022014633A (es) Metodos para detectar norovirus.
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
EA201691352A1 (ru) Диагностика рака легкого с помощью циркулирующих опухолевых клеток
BR112016014010A2 (pt) métodos para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv), para diferenciação entre animais infectados com csfv tipo selvagem e animais que foram vacinados contra csfv e para controlar uma infecção com csfv tipo selvagem, kit de teste de diagnóstico, e, uso de um carreador
MX2018014702A (es) Métodos para predecir el beneficio terapéutico de la terapia con anti-cd19 en pacientes.
MX2022014741A (es) Metodos para detectar bordetella.
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
EA201691682A1 (ru) Способы анализирования редких циркулирующих в крови клеток
EP3414012A4 (en) DEVICE AND CASSETTE FOR DIRECT SAMPLING
AR105379A1 (es) Dispositivo para detectar proteínas mal plegadas y sus métodos de uso
EP3938780A4 (en) BLOOD TEST DEVICE FOR HEMOLYSIS DETECTION
AR109279A1 (es) Anticuerpos anti plazomicina y métodos de uso de los mismos